Kevin W. Garey

机构：University of Houston · ORCID：0000-0003-2063-7503

发表论文 451 篇 · 总被引 16937 次 · h-index 58

代表论文

• Clostridioides difficile is a bacterial priority pathogen (2025 · Anaerobe · 被引 12)
• Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study (2025 · The Lancet Microbe · 被引 9)
• Prebiotics Improve Blood Pressure Control by Modulating Gut Microbiome Composition and Function: A Systematic Review and Meta-Analysis (2025 · Nutrients · 被引 6)
• Effectiveness of Continuous Glucose Monitoring in a Pharmacist-Run Collaborative Drug Therapy Management Service for Underserved Individuals With Diabetes: A Quasi-Experimental Study (2025 · Clinical Diabetes · 被引 5)
• Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes (2025 · mSystems · 被引 5)
• Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals (2025 · Clinical Infectious Diseases · 被引 4)